#clinicaltrials

· 1mo ago

The FDA approved daraxonrasib for defined groups of adults with metastatic pancreatic adenocarcinoma after a 500-person trial doubled median survival versus chemotherapy. The once-daily RAS inhibitor is not a cure, carries serious risks and has a list price near $39,800 per month.

Good News Community @Good_News_Community@mastodon.cosmicnation.co

· 2mo ago

An experimental Alzheimer's drug lowered tau protein and showed early signs of slowing decline in a study of about 400 people. Larger trials still need to confirm the benefit, but it points to a new treatment path beyond amyloid. Read more: https://apnews.com/article/d58728ee8f7d9dfd9ec8de416cddd75d @goodnews@fedigroups.social #GoodNews #Alzheimers #MedicalResearch #Dementia #HealthScience #ClinicalTrials

AP News

An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.

You've seen all posts